← FDA Drug Approvals (Drugs@FDA)
SEREVENT
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1997-09-19
Drug application
- FDA Application #
NDA020692- Application type
- New Drug Application
- Brand name
- SEREVENT
- Generic name
- SALMETEROL XINAFOATE
- Active ingredients
- SALMETEROL XINAFOATE
- Dosage form
- POWDER
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 1997-09-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown